5-Ethyl-2'-deoxyuridine as a systemic agent for treatment of herpes simplex virus encephalitis. Comparison of effects in a normal and immunosuppressed murine model.
D000818:Animals; D003857:Deoxyuridine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004660:Encephalitis / Q000188:drug therapy* / Q000276:immunology; D006561:Herpes Simplex / Q000188:drug therapy* / Q000276:immunology; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007275:Injections, Intravenous; D051379:Mice; D008815:Mice, Inbred Strains
C022811:edoxudin; D003857:Deoxyuridine